Ilan Ganot's most recent trade in Solid Biosciences Inc was a trade of 4,861 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,861 | 16,550 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,861 | 14,583 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 1,711 | 14,839 (0%) | 0% | 4.0 | 6,776 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 3,884 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 98,690 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 388 | 11,833 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 388 | 389 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 27 Jan 2025 | 144 | 11,689 (0%) | 0% | 3.1 | 448 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,994 | 12,501 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,994 | 5,988 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 4.31 per share. | 03 Jan 2025 | 1,056 | 11,445 (0%) | 0% | 4.3 | 4,551 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 1,553 | 0 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 1,553 | 9,969 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 02 May 2024 | 462 | 9,507 (0%) | 0% | 10.3 | 4,772 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 19,444 | 19,444 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 3,883 | 7,767 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 3,883 | 94,807 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 388 | 777 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 388 | 8,555 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ganot Ilan | Director | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 27 Jan 2024 | 139 | 8,416 (0%) | 0% | 8.0 | 1,111 | Common Stock |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 2,993 | 8,982 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 2,993 | 9,309 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 5.30 per share. | 03 Jan 2024 | 1,142 | 8,167 (0%) | 0% | 5.3 | 6,052 | Common Stock |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 1,583 | 0 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 1,583 | 90,924 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,583 | 87,758 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,583 | 3,166 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,553 | 4,640 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,553 | 1,553 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 4.85 per share. | 02 May 2023 | 487 | 4,153 (0%) | 0% | 4.9 | 2,364 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,584 | 86,175 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,584 | 4,749 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 3,883 | 85,973 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 3,883 | 11,650 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 1,382 | 84,591 (0%) | 0% | 7.5 | 10,351 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 388 | 1,519 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 388 | 1,165 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 141 | 1,378 (0%) | 0% | 7.5 | 1,056 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 23,950 | 23,950 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 11,975 | 11,975 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 6,333 | 6,333 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 46,600 | 46,600 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 10 Feb 2022 | 463 | 2,518 (0%) | 0% | 1.1 | 519 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 466,000 | 466,000 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 233,000 | 233,000 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 46,400 | 46,400 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 23,300 | 23,300 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 7.66 per share. | 12 Feb 2021 | 457 | 3,026 (0%) | 0% | 7.7 | 3,501 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 35,500 | 1,210,534 (2%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 35,500 | 0 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 10,713 | 1,199,821 (2%) | 0% | 6.1 | 65,776 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 438,000 | 438,000 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 8,100 | 8,100 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 27,027 | 1,175,034 (2%) | 0% | 3.7 | 100,000 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 800 | 3,737 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 800 | 0 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 12 Aug 2020 | 299 | 3,483 (0%) | 0% | 2.4 | 730 | Common Stock |
Solid Biosciences Inc | Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,350 | 1,350 | - | - | Employee Stock Option (Right to Buy) |